|
Name of Committee | Circulatory System Devices Panel |
Date and Time | The meeting was held on the following dates:
Dec 7, 2006 8:00 AM - 5:30 PM
Dec 8, 2006 8:00 AM - 5:30 PM
|
Location | Hilton Washington DC North/Gaithersburg, Salons A, B, C, D and E 620 Perry Parkway
Gaithersburg
, MD |
Contact Information | James Swink, Center for Devices and Radiological Health (HFZ-450), Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 301-443-8262, ext. 163, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512625. Please call the Information Line for up-to-date information on this meeting. |
Agenda | The committee will discuss and make recommendations regarding issues related to stent thrombosis in coronary drug-eluting stents. Background information for the topic, including the agenda and questions for the committee, will be available to the public 1 business day before the meeting on the Internet at http://www.fda.gov/cdrh/panel (click on Upcoming CDRH Advisory Panel/Committee Meetings). |
Procedure | Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person on or before November 15, 2006. Oral presentations from the public will be scheduled on both days for approximately 1 hour at the beginning of committee deliberations and for approximately 1 hour near the end of the deliberations. Time allotted for each presentation may be limited. Those desiring to make formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before November 15, 2006. |
| Persons attending FDA’s advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. |
Conduct | FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at http://www.fda.gov/oc/advisory/ for procedures on public conduct during advisory committee meetings. |
Related Documents |
Agenda: | December 7, 2006 Meeting | |
Agenda: | December 8, 2006 Meeting | |
Brief Summary: | December 7 - 8, 2006 Meeting | |
Briefing: | December 7 - 8, 2006 Meeting | |
Minutes: | Final Minutes for December 7, 2006 Meeting | |
Minutes: | Final Minutes for December 8, 2006 Meeting | |
Notice of Meeting: | December 7 - 8, 2006 Meeting | |
Other: | Nature and Basis Statements of Conflict(s) of Interest | |
Other: | Consumer Qs&As on Drug-Eluting Stents | |
Questions: | December 7 - 8, 2006 Meeting | |
Roster: | December 7 - 8, 2006 Meeting | |
Slides: | December 7, 2006 Meeting | |
Slides: | December 8, 2006 Meeting | |
Transcript: | December 8, 2006 Meeting | |
Transcript: | December 7, 2006 Meeting | |
|
Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). |
|